vs
艾默生(EMR)与哈特福德(HIG)财务数据对比。点击上方公司名可切换其他公司
艾默生的季度营收约是哈特福德的1.1倍($4.3B vs $4.1B),艾默生净利率更高(13.9% vs 13.2%,领先0.8%),艾默生同比增速更快(4.1% vs -43.7%),过去两年艾默生的营收复合增速更高(-0.3% vs -20.8%)
艾默生是总部位于美国密苏里州圣路易斯的世界500强跨国企业,业务涵盖工业自动化设备、暖通控制系统、精密测量仪器的研发制造,同时面向工业、商业、消费级市场提供工程服务及对应软件工程解决方案。
哈特福德(The Hartford)是美国头部保险企业,位列2024年《财富》世界500强第162位,总部位于康涅狄格州哈特福德市。集团拥有200余年行业经验,在财产意外险、员工福利及共同基金领域处于领先地位,凭借优质服务、可持续运营与诚信经营广受认可。
EMR vs HIG — 直观对比
营收规模更大
EMR
是对方的1.1倍
$4.1B
营收增速更快
EMR
高出47.8%
-43.7%
净利率更高
EMR
高出0.8%
13.2%
两年增速更快
EMR
近两年复合增速
-20.8%
损益表 — Q1 FY2026 vs Q1 FY2026
| 指标 | ||
|---|---|---|
| 营收 | $4.3B | $4.1B |
| 净利润 | $605.0M | $536.0M |
| 毛利率 | 53.2% | — |
| 营业利润率 | 17.8% | — |
| 净利率 | 13.9% | 13.2% |
| 营收同比 | 4.1% | -43.7% |
| 净利润同比 | 3.4% | 12.0% |
| 每股收益(稀释后) | $1.07 | — |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比,按日历期对齐,财年错位的公司也能正确匹配
营收
EMR
HIG
| Q1 26 | — | $4.1B | ||
| Q4 25 | $4.3B | $7.3B | ||
| Q3 25 | $4.9B | $7.2B | ||
| Q2 25 | $4.6B | $7.0B | ||
| Q1 25 | $4.4B | $6.8B | ||
| Q4 24 | $4.2B | $6.9B | ||
| Q3 24 | $4.6B | $6.8B | ||
| Q2 24 | $4.4B | $6.5B |
净利润
EMR
HIG
| Q1 26 | — | $536.0M | ||
| Q4 25 | $605.0M | — | ||
| Q3 25 | $637.0M | $1.1B | ||
| Q2 25 | $586.0M | $995.0M | ||
| Q1 25 | $485.0M | $630.0M | ||
| Q4 24 | $585.0M | — | ||
| Q3 24 | $996.0M | $767.0M | ||
| Q2 24 | $329.0M | $738.0M |
毛利率
EMR
HIG
| Q1 26 | — | — | ||
| Q4 25 | 53.2% | — | ||
| Q3 25 | 51.9% | — | ||
| Q2 25 | 52.6% | — | ||
| Q1 25 | 53.5% | — | ||
| Q4 24 | 53.5% | — | ||
| Q3 24 | 51.3% | — | ||
| Q2 24 | 52.8% | — |
营业利润率
EMR
HIG
| Q1 26 | — | — | ||
| Q4 25 | 17.8% | 19.3% | ||
| Q3 25 | 16.4% | 18.2% | ||
| Q2 25 | 16.1% | 17.8% | ||
| Q1 25 | 14.2% | 11.5% | ||
| Q4 24 | 18.6% | 15.6% | ||
| Q3 24 | 14.7% | 14.1% | ||
| Q2 24 | 10.4% | 14.1% |
净利率
EMR
HIG
| Q1 26 | — | 13.2% | ||
| Q4 25 | 13.9% | — | ||
| Q3 25 | 13.1% | 14.9% | ||
| Q2 25 | 12.9% | 14.2% | ||
| Q1 25 | 10.9% | 9.3% | ||
| Q4 24 | 14.0% | — | ||
| Q3 24 | 21.6% | 11.4% | ||
| Q2 24 | 7.5% | 11.4% |
每股收益(稀释后)
EMR
HIG
| Q1 26 | — | — | ||
| Q4 25 | $1.07 | $3.96 | ||
| Q3 25 | $1.12 | $3.77 | ||
| Q2 25 | $1.04 | $3.44 | ||
| Q1 25 | $0.86 | $2.15 | ||
| Q4 24 | $1.02 | $2.88 | ||
| Q3 24 | $1.74 | $2.56 | ||
| Q2 24 | $0.57 | $2.44 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | ||
|---|---|---|
| 现金及短期投资手头流动性 | — | $1.7M |
| 总债务越低越好 | $7.6B | — |
| 股东权益账面价值 | $20.3B | $16.8M |
| 总资产 | $41.9B | $86.3M |
| 负债/权益比越低杠杆越低 | 0.37× | — |
8季度趋势,按日历期对齐
现金及短期投资
EMR
HIG
| Q1 26 | — | $1.7M | ||
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — |
总债务
EMR
HIG
| Q1 26 | — | — | ||
| Q4 25 | $7.6B | $4.4B | ||
| Q3 25 | $8.9B | $4.4B | ||
| Q2 25 | $8.3B | $4.4B | ||
| Q1 25 | $8.2B | $4.4B | ||
| Q4 24 | $6.6B | $4.4B | ||
| Q3 24 | $7.7B | $4.4B | ||
| Q2 24 | $7.1B | $4.4B |
股东权益
EMR
HIG
| Q1 26 | — | $16.8M | ||
| Q4 25 | $20.3B | $19.0B | ||
| Q3 25 | $20.3B | $18.4B | ||
| Q2 25 | $19.9B | $17.5B | ||
| Q1 25 | $19.2B | $16.8B | ||
| Q4 24 | $20.5B | $16.4B | ||
| Q3 24 | $21.6B | $17.0B | ||
| Q2 24 | $20.8B | $15.7B |
总资产
EMR
HIG
| Q1 26 | — | $86.3M | ||
| Q4 25 | $41.9B | $86.0B | ||
| Q3 25 | $42.0B | $85.0B | ||
| Q2 25 | $42.5B | $83.6B | ||
| Q1 25 | $42.0B | $82.3B | ||
| Q4 24 | $42.6B | $80.9B | ||
| Q3 24 | $44.2B | $81.2B | ||
| Q2 24 | $45.6B | $79.0B |
负债/权益比
EMR
HIG
| Q1 26 | — | — | ||
| Q4 25 | 0.37× | 0.23× | ||
| Q3 25 | 0.44× | 0.24× | ||
| Q2 25 | 0.42× | 0.25× | ||
| Q1 25 | 0.42× | 0.26× | ||
| Q4 24 | 0.32× | 0.27× | ||
| Q3 24 | 0.36× | 0.26× | ||
| Q2 24 | 0.34× | 0.28× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | ||
|---|---|---|
| 经营现金流最新季度 | $699.0M | — |
| 自由现金流经营现金流 - 资本支出 | $602.0M | — |
| 自由现金流率自由现金流/营收 | 13.9% | — |
| 资本支出强度资本支出/营收 | 2.2% | — |
| 现金转化率经营现金流/净利润 | 1.16× | — |
| 过去12个月自由现金流最近4个季度 | $4.4B | — |
8季度趋势,按日历期对齐
经营现金流
EMR
HIG
| Q1 26 | — | — | ||
| Q4 25 | $699.0M | $5.9B | ||
| Q3 25 | $3.1B | $1.8B | ||
| Q2 25 | $1.1B | $1.3B | ||
| Q1 25 | $241.0M | $985.0M | ||
| Q4 24 | $777.0M | $5.9B | ||
| Q3 24 | $3.3B | $1.7B | ||
| Q2 24 | $1.1B | $1.3B |
自由现金流
EMR
HIG
| Q1 26 | — | — | ||
| Q4 25 | $602.0M | $5.8B | ||
| Q3 25 | $2.7B | $1.8B | ||
| Q2 25 | $977.0M | $1.3B | ||
| Q1 25 | $154.0M | $947.0M | ||
| Q4 24 | $694.0M | $5.8B | ||
| Q3 24 | $2.9B | $1.6B | ||
| Q2 24 | $998.0M | $1.2B |
自由现金流率
EMR
HIG
| Q1 26 | — | — | ||
| Q4 25 | 13.9% | 78.4% | ||
| Q3 25 | 54.9% | 24.8% | ||
| Q2 25 | 21.5% | 17.9% | ||
| Q1 25 | 3.5% | 13.9% | ||
| Q4 24 | 16.6% | 83.8% | ||
| Q3 24 | 63.1% | 24.0% | ||
| Q2 24 | 22.8% | 18.5% |
资本支出强度
EMR
HIG
| Q1 26 | — | — | ||
| Q4 25 | 2.2% | 2.3% | ||
| Q3 25 | 8.9% | 0.6% | ||
| Q2 25 | 2.0% | 0.6% | ||
| Q1 25 | 2.0% | 0.6% | ||
| Q4 24 | 2.0% | 2.1% | ||
| Q3 24 | 9.1% | 0.9% | ||
| Q2 24 | 2.1% | 0.9% |
现金转化率
EMR
HIG
| Q1 26 | — | — | ||
| Q4 25 | 1.16× | — | ||
| Q3 25 | 4.86× | 1.70× | ||
| Q2 25 | 1.83× | 1.30× | ||
| Q1 25 | 0.50× | 1.56× | ||
| Q4 24 | 1.33× | — | ||
| Q3 24 | 3.35× | 2.19× | ||
| Q2 24 | 3.31× | 1.71× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
EMR
| Other | $1.8B | 41% |
| Software And Systems | $1.0B | 24% |
| Intelligent Devices | $996.0M | 23% |
| Safety And Productivity | $503.0M | 12% |
HIG
| Earned premiums | $3.6B | 88% |
| Other | $486.0M | 12% |
| Fee income | $12.0M | 0% |